Literature DB >> 4025468

Comparative toxicity of intravitreal aminoglycoside antibiotics.

D J D'Amico, L Caspers-Velu, J Libert, E Shanks, M Schrooyen, L A Hanninen, K R Kenyon.   

Abstract

We compared the toxicity of the aminoglycoside antibiotics (tobramycin, amikacin, netilmicin, and kanamycin) by ophthalmoscopy, light and electron microscopy, and electro-retinography after intravitreal injection in rabbits in doses ranging from 100 to 3,000 micrograms. The earliest manifestations of toxicity were confined to the outer retina with each drug, with lamellar lysosomal inclusions in the retinal pigment epithelium as the earliest finding. However, the aminoglycosides displayed marked differences in the threshold dose required to produce toxic reactions, permitting the following ordering of toxicity: (most toxic) gentamicin greater than netilmicin = tobramycin greater than amikacin = kanamycin (least toxic).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025468     DOI: 10.1016/0002-9394(85)90792-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

1.  The dangers of sublethal carvacrol exposure: increases in virulence of Bacillus cereus during endophthalmitis.

Authors:  Niloofar Rajabli; Lauren Williamson; Pierre S Nimmer; Marie Kelly-Worden; Jill S Bange; Yenling Ho; John L McKillip
Journal:  Int J Biochem Mol Biol       Date:  2018-10-08

2.  Intravitreal antibiotic therapy with vancomycin and aminoglycoside: examination of the retinal toxicity of repetitive injections after vitreous and lens surgery.

Authors:  B S Oum; D J D'Amico; H W Kwak; K W Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Topical and intravenous gentamicin in traumatically lacerated eyes.

Authors:  M O Yoshizumi; M J Leinwand; J Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

4.  Diagnosis and therapy of bacterial endophthalmitis, and serum levels of inflammation markers.

Authors:  V Huber-Spitzy; E Arocker-Mettinger; K Herkner; M Schiffbänker; L Georgiew; F J Steinkogler; G Grabner
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 5.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

6.  Toxicity and clearance of intravitreal cefotetan.

Authors:  W Philipp; K Schmid; H J Steiner; B Pümpel; F Allerberger; H P Aichberger; W Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 7.  Antibiotic therapy for ocular infection.

Authors:  R W Snyder; D B Glasser
Journal:  West J Med       Date:  1994-12

Review 8.  Bacillus cereus endophthalmitis.

Authors:  D B David; G R Kirkby; B A Noble
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

9.  Retinotoxicity of 1,4,-bis(4-aminophenoxy)-2-phenylbenzene (2-phenyl-APB-144) in albino and pigmented rats.

Authors:  K P Lee; R Valentine
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

10.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.